Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer

McGill University

$67,500.00

Defining mechanisms of obesity-accelerated breast cancer progression

FY 2024-25

Summary
BACKGROUND: Breast cancer is the most commonly diagnosed cancer in Canadian women and obesity is associated with a 30-40% increased risk of recurrence and cancer-specific mortality in early-stage breast cancer. While the past decades have seen significant advances in breast cancer treatment, the global rise in obesity threatens to undermine these gains. In obesity, excess energy is stored primarily within white adipose tissue. However, a second type of fat, called brown adipose tissue consumes copious amounts of circulating nutrients to support the dissipation of energy in a process called thermogenesis. PROGRESS: We and others have shown that, compared to lean mice, breast cancer progression is greater in obese mice. However, how the genes within breast cancer cells interact with the host metabolic milieu to influence tumor progression is unknown. We have established GFP-Cas9-expressing breast cancer (Py8119 and Py230) cells and have confirmed that these cells retain the propensity to form larger primary tumors in obese, compared to lean, mice. We are now poised to identify the genes within breast cancer cells that respond both positively and negatively to the obese host using genome-wide in vivo CRISPR (clustered regularly interspaced short palindromic repeats) screening. To drive its thermogenic properties, brown adipose tissue consumes a vast amount of metabolic fuel. Cancer cells also require large quantities of nutrients to drive their proliferation and survival. Thus, it is possible that thermogenic brown adipose tissue may “starve” cancer cells through competition for cellular/metabolic resources. Uncoupling protein 1 (UCP1) is a mitochondrial inner membrane protein that is a key mediator of thermogenesis. The conventional mouse model used in the field is one where Ucp1 is deleted from birth (germline Ucp1-/-). All published studies that connect brown adipose tissue to cancer have used germline Ucp1-/- mice. However, while this mouse model has advanced our understanding of adipocyte thermogenesis, there are limitations to its use because it acquires secondary changes beyond UCP1 loss due to Ucp1 inactivation from birth and from non-adipocytes. To circumvent these off target multifaceted disruptions in germline Ucp1-/- mice, my lab has constructed a novel adipocyte-selective and inducible mouse model of Ucp1 deletion (Ucp1AdipoqCreERT2). Importantly, the brown adipose tissue of these mice does not exhibit adaptive secondary changes that are associated with germline deletion of Ucp1, allowing us to define the role of thermogenesis in breast cancer progression with unprecedented accuracy. HYPOTHESIS: We hypothesize that obesity or impaired thermogenic function of adipose tissue provides a proliferative/survival advantage to cancer cells, supporting enhanced tumor progression. RESEARCH AIMS: Aim 1 will utilize functional genetic screening to define how obesity accelerates breast cancer progression in vivo. Having established that our GFP-Cas9-expressing breast cancer cells retain the propensity to form larger tumors in obese mice, compared to lean mice, we are poised to use genome-wide CRISPR screening to integrate cancer genomics and mouse modeling for discovery of tumor modulators in vivo. We will infect these genetically-engineered cells with a genome-wide sgRNA library, inject them into the left 4th mammary fat pad of obese and lean female C57Bl/6J mice, track tumor growth and assess sgRNA incorporation by performing tumor DNA sequencing when tumors reach humane endpoint.
Program
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
537938
Name
Kazak Lawrence
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Defining mechanisms of obesity-accelerated breast cancer progression
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$67,500
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Keyworddelim
Cancer
Abstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer in Canadian women and obesity is associated with a 30-40% increased risk of recurrence and cancer-specific mortality in early-stage breast cancer. While the past decades have seen significant advances in breast cancer treatment, the global rise in obesity threatens to undermine these gains. In obesity, excess energy is stored primarily within white adipose tissue. However, a second type of fat, called brown adipose tissue consumes copious amounts of circulating nutrients to support the dissipation of energy in a process called thermogenesis. PROGRESS: We and others have shown that, compared to lean mice, breast cancer progression is greater in obese mice. However, how the genes within breast cancer cells interact with the host metabolic milieu to influence tumor progression is unknown. We have established GFP-Cas9-expressing breast cancer (Py8119 and Py230) cells and have confirmed that these cells retain the propensity to form larger primary tumors in obese, compared to lean, mice. We are now poised to identify the genes within breast cancer cells that respond both positively and negatively to the obese host using genome-wide in vivo CRISPR (clustered regularly interspaced short palindromic repeats) screening. To drive its thermogenic properties, brown adipose tissue consumes a vast amount of metabolic fuel. Cancer cells also require large quantities of nutrients to drive their proliferation and survival. Thus, it is possible that thermogenic brown adipose tissue may “starve” cancer cells through competition for cellular/metabolic resources. Uncoupling protein 1 (UCP1) is a mitochondrial inner membrane protein that is a key mediator of thermogenesis. The conventional mouse model used in the field is one where Ucp1 is deleted from birth (germline Ucp1-/-). All published studies that connect brown adipose tissue to cancer have used germline Ucp1-/- mice. However, while this mouse model has advanced our understanding of adipocyte thermogenesis, there are limitations to its use because it acquires secondary changes beyond UCP1 loss due to Ucp1 inactivation from birth and from non-adipocytes. To circumvent these off target multifaceted disruptions in germline Ucp1-/- mice, my lab has constructed a novel adipocyte-selective and inducible mouse model of Ucp1 deletion (Ucp1AdipoqCreERT2). Importantly, the brown adipose tissue of these mice does not exhibit adaptive secondary changes that are associated with germline deletion of Ucp1, allowing us to define the role of thermogenesis in breast cancer progression with unprecedented accuracy. HYPOTHESIS: We hypothesize that obesity or impaired thermogenic function of adipose tissue provides a proliferative/survival advantage to cancer cells, supporting enhanced tumor progression. RESEARCH AIMS: Aim 1 will utilize functional genetic screening to define how obesity accelerates breast cancer progression in vivo. Having established that our GFP-Cas9-expressing breast cancer cells retain the propensity to form larger tumors in obese mice, compared to lean mice, we are poised to use genome-wide CRISPR screening to integrate cancer genomics and mouse modeling for discovery of tumor modulators in vivo. We will infect these genetically-engineered cells with a genome-wide sgRNA library, inject them into the left 4th mammary fat pad of obese and lean female C57Bl/6J mice, track tumor growth and assess sgRNA incorporation by performing tumor DNA sequencing when tumors reach humane endpoint.
Competitiondate
202502
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kazak, Lawrence
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $67,500~ $0~